Farms.com Home   News

Canola prices struggling

"Canola prices have been struggling this crop year to the frustration of producers who had been expecting a seasonal post-harvest price improvement," says Neil Blue, provincial crops market analyst with the Alberta government. "There are a number of factors affecting the canola market."

Canola prices started to rise following the 2021 drought in Alberta and some other oilseed producing countries. Post-Covid economic improvement was also a demand supporting factor.

Following the high prices of the 2021-22 crop year, world oilseed production rebounded. Australia produced a record canola crop last year and was a major competitor on the world market. Brazil produced a record soybean crop earlier this year and is currently projected to produce about the same volume in 2024, despite some adverse weather to date.

"Although a certain level of Canadian canola demand is stable, at high prices the more flexible demand will move to less costly alternative vegetable oil sources," explains Blue. "A canola negative so far this crop year is lower Canadian canola exports. According to weekly Canadian Grain Commission data, canola exports at the one-third point of this crop year are down from the year ago pace by 620,000 tonnes, or 23%. Fortunately, Canadian crushers have used 300,000 tonnes more canola than a year ago to date, but total canola usage is still lower."

Statistics Canada in early December bumped up its estimate of 2023 Canadian canola production by one million tonnes to 18.33 million tonnes. Although the higher production estimate was expected, confirmation of the higher production with exports lagging last year implies the potential for a sharp rise in canola carryover.

"The major positive for canola prices is continuing strong crusher demand. Crushing margins remain profitable, implied by the estimated values of canola meal and canola oil relative to canola seed. Both canola product markets are well developed."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.